| 24.07 12:50 | dpa-AFX: ROUNDUP: Boston Scientific Boosts FY24 Outlook |
| 24.07 12:48 | dpa-AFX: *BOSTON SCIENTIFIC SEES Q3 EPS ON GAAP BASIS IN RANGE OF $0.36 TO $0.38; ADJ EPS, EXCL CERTAIN CHARGES, OF $0.57 TO $0.59 |
| 24.07 12:45 | dpa-AFX: *BOSTON SCIENTIFIC SEES Q3 NET SALES GROWTH IN RANGE OF ABOUT 13-15% ON BOTH A REPORTED BASIS AND ORGANIC BASIS |
| 24.07 12:44 | dpa-AFX: *BOSTON SCIENTIFIC ESTIMATES GAAP EPS OF $1.34 TO $1.38; ADJ EPS, EXCLUDING CERTAIN CHARGES, OF $2.38 TO $2.42 |
| 24.07 12:44 | dpa-AFX: *BOSTON SCIENTIFIC ESTIMATES NET SALES GROWTH FOR 2024 |
| 24.07 12:44 | dpa-AFX: *BOSTON SCIENTIFIC ANNOUNCES AGREEMENT TO ACQUIRE SILK ROAD MEDICAL |
| 24.07 12:43 | dpa-AFX: *BOSTON SCIENTIFIC Q2 GAAP NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $324 MLN VS $261 MLN LAST YEAR |
| 24.07 12:43 | dpa-AFX: *BOSTON SCIENTIFIC Q2 SALES $4.120 BLN, UP 14.5% ON REPORTED BASIS, 16.1% ON OPERATIONAL BASIS, 14.7% ON ORGANIC BASIS |
| 24.07 12:33 | dpa-AFX: Boston Scientific Corp Q2 Profit Increases, Beats Estimates |
| 24.07 12:32 | dpa-AFX: *BOSTON SCIENTIFIC Q2 EPS $0.22; ADJ EPS $0.62 |
| 24.07 12:04 | dpa-AFX: Boston Scientific Q2 24 Earnings Conference Call At 8:00 AM ET |
| 18.06 22:10 | MÄRKTE USA/Durchatmen nach Rally - Nvidia wertvollstes US-Unternehmen |
| 18.06 18:20 | MÄRKTE USA/Verschnaufpause nach Rekordjagd |
| 18.06 15:43 | MÄRKTE USA/Wall Street kaum bewegt - Anleihen von Einzelhandel gestützt |
| 18.06 15:10 | MÄRKTE USA/Anleihen von Einzelhandel gestützt - Wall Street kaum bewegt |
| 18.06 15:04 | MÄRKTE USA/Anleihen von Einzelhandel gestützt - Wall Street kaum bewegt |
| 18.06 13:17 | dpa-AFX: Boston Scientific To Acquire Silk Road Medical For $27.50/share In Deal Valued At About $1.16 Bln |
| 18.06 13:02 | dpa-AFX: *BOSTON SCIENTIFIC AGREES TO BUY SILK ROAD MEDICAL FOR $27.50/SHR, REFLECTING ENTERPRISE VALUE OF ABOUT $1.16 BLN |
| 30.05 12:44 | dpa-AFX: *GOLDMAN STARTS BOSTON SCIENTIFIC WITH 'BUY' - PRICE TARGET 90 USD |
| 30.05 12:44 | dpa-AFX: *GOLDMAN STARTET BOSTON SCIENTIFIC MIT 'BUY' - ZIEL 90 USD |
|
|
